Overview
The global plastic surgery market reached US$ 69.7 billion in 2023 and is expected to reach US$ 158.7 billion by 2031, growing at a CAGR of 11.1% during the forecast period 2024-2031.
Plastic surgery is a surgical specialty involved with both the improvement of a person's appearance and the reconstruction of facial and body tissue defects due to illness, trauma, or birth disorders. Plastic surgery restores and improves function, as well as appearance. It can involve surgery on any part of the anatomy, except the central nervous system. A surgical specialty known as plastic surgery deals with the reconstruction, augmentation, or change of the human body. Cosmetic surgery and reconstructive surgery are the two subcategories of plastic surgery.
Moreover, rising consumer demand for these plastic procedures due to the increasing geriatric population, adoption of minimally invasive procedures, reduced procedural costs, an increase in the number of authorized service providers in the market, and an increase in the number of new product launches are driving up the plastic surgery market size. The market is experiencing a growth in demand for products from North American areas as a result of the development of research in these fields. Significant competitors like Allergan Aesthetics (AbbVie Inc.), Merz Aesthetics, Cynosure LLC, and others actively operating in the ma rket.
Executive Summary
Market Dynamics: Drivers & Restraints
Increasing demand for plastic surgery procedures
The increasing demand for plastic surgery procedures is expected to be a significant factor in the growth of the global plastic surgery market. Factors such as the increasing geriatric population, increase in the number of scars and injuries, technological advancements, recent launches, and approvals increase the demand for plastic surgery procedures. The growing geriatric population is expected to have a substantial impact on the global plastic surgery market. As life expectancy increases and the older population grows, there is a greater need for aesthetic treatments that address age-related issues such as wrinkles, sagging skin, and volume loss. Facelifts, dermal fillers, and Botox injections are becoming increasingly popular among elderly individuals as a way to improve their appearance.
The rising occurrence of traffic accidents and burn injuries has resulted in a greater number of patients requiring scar therapy, driving up demand for various plastic surgery operations aimed at scar revision and aesthetic improvement. For instance, according to the World Health Organization, an estimated 180,000 deaths every year are caused by burns. The vast majority occur in low- and middle-income countries. In India, over 1 million people are moderately or severely burnt every year.
The number of procedures performed is increasing day by day due to the need for beautification and to improve appearance. For instance, according to the American Society of Plastic Surgeons, in 2023, in the US, a total of 304,181 Breast augmentation procedures, 347,782 liposuction procedures, and 120,747 eyelid surgeries and procedures were performed.
The increasing geriatric population is the major driver for market growth in the forecast period. As the geriatric population across the globe is rising, the demand for plastic surgery is increasing. For instance, as per the United Nations, in 2023, the global population above 60 years of age accounted for 1.06 billion, and the same age group population is expected to rise to 1.33 billion in 2030. For the increasing geriatric population, there are recent launches for plastic surgery and treatment. For instance, in September 2024, Allergan Aesthetics, an AbbVie company announced that BOTOX Cosmetic (onabotulinumtoxinA) is now available in China to treat masseter muscle predominance (MMP). The masseter muscle is one of the lower face's chewing muscles, and its predominance can result in a wide and square lower face shape1. The China National Medical Product Administration (NMPA) recently approved BOTOX Cosmetic to temporarily enhance the appearance of significant to extremely marked MMP in adults. BOTOX Cosmetic is the first neurotoxin approved in China for MMP, and it includes the defined dose, strong clinical data, and physician training associated with on-label treatment.
Side effects associated with plastic surgery
Factors such as side effects associated with plastic surgery are expected to hamper the global plastic surgery market. Infections, severe bleeding, scarring, and anesthetic or implant-related adverse responses are all common problems. These dangers not only endanger patient safety, but they can also lead to dissatisfaction with results, resulting in legal liability for practitioners and harming their professional reputations. For instance, according to the National Institute of Health, long-term adverse events such as persistent granulomas and infections are being reported. These may be due to laxity in aseptic procedures or the formation of biofilms. Adverse events with fillers can not only be persistent but can also lead to serious complications such as permanent blindness.
Segment Analysis
The global plastic surgery market is segmented based on surgical procedure type gender, age group, end-user, and region.
The cosmetic (minimally-invasive) procedures segment is expected to dominate the global plastic surgery market share
The segment of minimally invasive cosmetic operations is expected to dominate the global plastic surgery market as a result of technical improvements, patient preferences, recent launches with technological advancements, and the inherent benefits of these procedures. Minimally invasive therapies, such as Botox injections, dermal fillers, and laser treatments, have grown in favor since they often require minimal incisions or none at all. This strategy lessens the physical damage associated with standard operations, as well as scars and recovery time, making these solutions more appealing to a broader audience.
Due to increasing demand for minimally invasive procedures, there are so many new launches, especially in the lasers section. For instance, in September 2023, Cutera, Inc. a global leader in aesthetic and dermatology solutions, announced the launch of Secret DUO, an innovative skin resurfacing and revitalization platform that utilizes dual non-ablative fractional technologies. Each modality can be used individually or in combination to target a wide range of aesthetic indications. It is Optimized to treat varying layers of the skin; the Secret DUO is equipped with a radio frequency microneedling (RFMN) handpiece along with a fractional non-ablative 1540 nm erbium glass laser. The unique pairing of these modalities allows practitioners to provide fully customizable solutions for fine lines, texture, pigment, stretch marks, and scars.
Geographical Analysis
North America is expected to hold a significant position in the global plastic surgery market share
North America is expected to hold a significant portion of the global plastic surgery market. North America is anticipated to play a leading position in the global plastic surgery market owing to various factors such as the increasing geriatric population, technological advancements, recent launches and approvals, and the presence of strong players in this region. In this region, there is an increasing geriatric population which leads growth of the market in this region due to skin issues faced by the geriatric population. For instance, according to the Pew Research Center, the number of Americans ages 100 and older is projected to more than quadruple over the next three decades, from an estimated 101,000 in 2024 to about 422,000 in 2054, according to projections from the U.S. Census Bureau.
Due to the presence of the major players, there are recent launches and approvals in this region which makes this region hold a significant position in the global plastic surgery market. For instance, in January 2023, Reveal Lasers LLC announced the launch of the AlloraPro Laser Workstation, a state-of-the-art device designed for permanent hair reduction and skin rejuvenation treatments. The device's intuitive user interface has color-coded screens based on the active wavelength, allowing professionals to customize treatments for each patient. The strategic partnerships in this region are also one of the main reasons for the market to prosper in this region. For instance, in January 2024, United Aesthetics Alliance established to consolidate market-leading, clinically differentiated plastic surgery practices and affiliated medical spa service providers, announced that it has formed a new partnership with the Bengtson Center for Aesthetics & Plastic Surgery. BCAPS, headquartered in Grand Rapids, MI, is a leading plastic surgery and aesthetics provider in West Michigan and it is led by two recognized board-certified plastic surgeons.
Asia Pacific is growing at the fastest pace in the global plastic surgerymarket
The Asia Pacific region is witnessing rapid expansion in the plastic surgery market, propelled by economic advancement, an increasing geriatric population, and technological advancements. This expansion is especially evident in nations such as Korea, Japan, and India, where investments in dermatology, skincare, and wellness, and awareness about plastic surgery procedures have been increasing day by day during recent times. There are recent approvals and launches in this region which propels the market. For instance, in May 2024, Korean startup MediThinQ announced the launch of its SCOPEYE 3D Micro Surgery Solution, which uses the latest Eyes Up Display technology for improving precision across medical specialties. The SCOPEYE 3D Micro Surgery Solution’s portability and space-saving features make it suitable for a wide array of medical procedures, including microsurgery, dental procedures, plastic surgery, ophthalmology, hair transplant surgery, and dermatology.
Competitive Landscape
The major global players in the global plastic surgery market include Allergan Aesthetics (AbbVie Inc.), Alma Lasers, Cynosure LLC, Galderma, Bausch Health Companies Inc., Merz Aesthetics, Candela Corporation, Evolus, Inc., Lumenis Be Ltd., GC Aesthetics among others.
Key Developments
• In May 2023, the U.S. FDA approved SKINVIVE by JUVÉDERM for enhancing the skin softness of the cheeks in individuals over the age of 21, according to a statement from Allergan Aesthetics, a division of AbbVie. The sole and first intradermal microdroplet injection of hyaluronic acid (HA) for skin smoothness to be made available in the United States is called SKINVIVE by JUVÉDERM. With proper care, benefits can last up to six months. Smooth, injectable HA gel called SKINVIVE by JUVÉDERM includes a trace dose of lidocaine, a local anesthetic.
- In June 2023, Restylane Eyelight was approved by the U.S. Food and Drug Administration (FDA) for the treatment of dark shadows under the eyes in individuals over the age of 21. The first and sole product in the United States designed using NASHA Technology addressing volume loss beneath the eyes, Restylane Eyelight is a dermal filler made of hyaluronic acid (HA) that gives patients results that seem natural.
Emerging Players
MediThinQ, Avance Innovation, and ReConstruct Bio among others
| Metrics | Details | |
| CAGR | 11.1% | |
| Market Size Available for Years | 2022-2031 | |
| Estimation Forecast Period | 2024-2031 | |
| Revenue Units | Value (US$ Mn) | |
| Segments Covered | Surgical Procedure Type | Reconstructive Surgical Procedure, Cosmetic (aesthetic) Surgical Procedure, Cosmetic (Minimally-Invasive) Procedures |
| Gender | Female, Male | |
| Age Group | 13-19 yrs, 20-29 yrs, 30-39 yrs, 40-54 yrs, 55-69 yrs, 70+ yrs | |
| End-User | Hospitals, Surgical Centers/ Clinics, Others | |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa | |
Why Purchase the Report?
- Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
- Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
- Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
- Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
- Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
- Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
- Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
- Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
- Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
- Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
- Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
- Post-market Surveillance: Uses post-market data to enhance product safety and access.
- Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
The global plastic surgery market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.
Target Audience 2023
- Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
- Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
- Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
- Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
- Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
- Supply Chain: Distribution and Supply Chain Managers.
- Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
- Academic & Research: Academic Institutions.
